SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-24-025449
Filing Date
2024-06-27
Accepted
2024-06-27 16:43:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 160613
  Complete submission text file 0001493152-24-025449.txt   162443
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80470 | Film No.: 241079863
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 460 PARK AVENUE 22ND FLOOR NEW YORK NY 10022
Business Address 460 PARK AVENUE 22ND FLOOR NEW YORK NY 10022 646-942-5700
DG Capital Management, LLC (Filed by) CIK: 0001512716 (see all company filings)

IRS No.: 208404862 | Fiscal Year End: 1231
Type: SC 13G